BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zerbato V, Di Bella S, Giuffrè M, Jaracz AW, Gobbo Y, Luppino D, Macor P, Segat L, Koncan R, D'Agaro P, Valentini M, Crocé LS, Ruscio M, Luzzati R. High fecal calprotectin levels are associated with SARS-CoV-2 intestinal shedding in COVID-19 patients: A proof-of-concept study. World J Gastroenterol 2021; 27(22): 3130-3137 [PMID: 34168414 DOI: 10.3748/wjg.v27.i22.3130]
URL: https://www.wjgnet.com/2307-8960/full/v27/i22/3130.htm
Number Citing Articles
1
Pavel Frühauf. Fecal calprotectinPediatrie pro praxi 2022; 23(3): 243 doi: 10.36290/ped.2022.051
2
Aditya Riadi Syafei, Titong Sugihartono, Iswan Abbas Nusi, Poernomo Boedi Setiawan, Herry Purbayu, Ummi Maimunah, Ulfa Kholili, Budi Widodo, Husin Thamrin, Amie Vidyani, Hasan Maulahela, Yoshio Yamaoka, Muhammad Miftahussurur. Viral load and gastrointestinal inflammation in COVID-19 patientsF1000Research 2022; 11: 784 doi: 10.12688/f1000research.120611.1
3
Chang Shannon Lee. Differential Diagnosis of Acute DiarrheaThe Journal for Nurse Practitioners 2022; 18(2): 164 doi: 10.1016/j.nurpra.2021.10.012
4
Deasy Natalia Adriana, Titong Sugihartono, Iswan Abbas Nusi, Poernomo Boedi Setiawan, Herry Purbayu, Ummi Maimunah, Ulfa Kholili, Budi Widodo, Husin Thamrin, Amie Vidyani, Hasan Maulahela, Yoshio Yamaoka, Muhammad Miftahussurur. Role of fecal calprotectin as a hypoxic intestinal damage biomarker in COVID-19 patientsGut Pathogens 2022; 14(1) doi: 10.1186/s13099-022-00507-y
5
Ai Kato, Ayumi Yoshifuji, Kohji Komori, Kotaro Aoki, Daisuke Taniyama, Motoaki Komatsu, Kentaro Fujii, Kuniko Yamada, Yoshikazu Ishii, Takahide Kikuchi, Munekazu Ryuzaki. A case of Bacillus subtilis var. natto bacteremia caused by ingestion of natto during COVID-19 treatment in a maintenance hemodialysis patient with multiple myelomaJournal of Infection and Chemotherapy 2022; 28(8): 1212 doi: 10.1016/j.jiac.2022.05.006
6
Haoran Zhang, Qingyu Zhang, Kun Liu, Zenong Yuan, Xiqiang Xu, Jun Dong. Elevated level of circulating calprotectin correlates with severity and high mortality in patients with COVID‐19Immunity, Inflammation and Disease 2024; 12(3) doi: 10.1002/iid3.1212
7
Aaron Lerner, Carina Benzvi. Autoimmunity, COVID-19, Post-COVID19 Syndrome and COVID-19 Vaccination2023; : 451 doi: 10.1016/B978-0-443-18566-3.00009-8
8
L.D. Sadretdinova, Kh.Kh. Gantseva, D.S. Vishnyakov, V.B. Golubyatnikov, D.Kh. Kalimullina, V.N. Pavlov, A.V. Tyurin. Gastrointestinal injury in COVID-19Profilakticheskaya meditsina 2022; 25(7): 106 doi: 10.17116/profmed202225071106
9
Allen Pai, Yung‐Heng Lee, Meng‐Yu Ko, Po‐Ku Chen. Comment on fecal calprotectin as a biomarker of microscopic bowel inflammation in patients with spondyloarthritisInternational Journal of Rheumatic Diseases 2023; 26(1): 172 doi: 10.1111/1756-185X.14460
10
Kuan‐Kai Tung, Shih‐Tien Chen, Cheng‐Hung Lee, Chun‐Fang Tung, James Cheng‐Chung Wei. Calprotectin in spondyloarthritis and gut inflammation, is it clinically meaningful?International Journal of Rheumatic Diseases 2023; 26(4): 609 doi: 10.1111/1756-185X.14619
11
Elisaveta Snezhkova, Heinz Redl, Johannes Grillari, Marcin Osuchowski. Activated Carbon for Sepsis Prevention and Intervention: A Modern Way of Utilizing Old TherapiesC 2023; 9(3): 72 doi: 10.3390/c9030072
12
Jessica S. Smyth, Jennifer K. Truong, Anuradha Rao, Ruxian Lin, Jennifer Foulke-Abel, Luciano Adorini, Mark Donowitz, Paul A. Dawson, Stephen J. Keely. Farnesoid X receptor enhances epithelial ACE2 expression and inhibits virally induced IL-6 secretion: implications for intestinal symptoms of SARS-CoV-2American Journal of Physiology-Gastrointestinal and Liver Physiology 2023; 325(5): G446 doi: 10.1152/ajpgi.00099.2023
13
Mauro Giuffrè, Luigi Vetrugno, Stefano Di Bella, Rita Moretti, Debora Berretti, Lory Saveria Crocè. Calprotectin and SARS-CoV-2: A Brief-Report of the Current LiteratureHealthcare 2021; 9(8): 956 doi: 10.3390/healthcare9080956
14
M. A. Shevyakov. Probiotics: relevant during the coronavirus (COVID-19) infection pandemic?Meditsinskiy sovet = Medical Council 2022; (21-1): 165 doi: 10.21518/2079-701X-2021-21-1-165-172